Ying He

ORCID: 0000-0001-5793-3248 · 15 papers in corpus
case-report 2025
Gynecology and pelvic medicine ·doi:10.21037/gpm-24-42

BACKGROUND: Adenomyosis (AM) is a common benign gynecological disease, defined by the presence of endometrial glands and stroma deep within the myometrium, which is associated with hypertrophy and hyperplasia of the adjacent myometrium. It …

observational 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1627560

PURPOSE: To investigate the dynamic changes of serum Anti-Müllerian Hormone (AMH) and Inhibin B (INHB) during controlled ovarian hyperstimulation (COH) in patients with polycystic ovarian syndrome (PCOS) and analyze their correlation with C…

other 2025
Frontiers in immunology ·doi:10.3389/fimmu.2025.1741271

[This corrects the article DOI: 10.3389/fimmu.2021.641206.].

case-report 2025
International journal of clinical and experimental pathology ·doi:10.62347/jqlb5802

Female adnexal tumor of probable Wolffian origin (FATWO) is a rare gynecologic tumor. We describe a case of 53-year-old female patient in whom an adnexal mass was found. Microscopic examination revealed that the tumor arose in the adnexal s…

other 2024
Diagnostic pathology ·doi:10.1186/s13000-024-01477-2

BACKGROUND: Müllerian adenosarcoma, a rare malignancy, presents diagnostic and therapeutic challenges. In this study, we conducted an analysis of the clinicopathological characteristics of 22 adenosarcomas, with a particular focus on screen…

review 2023
International review of cell and molecular biology ·doi:10.1016/bs.ircmb.2022.11.004

Endometriosis is a common gynecological disorder defined by the presence of endometrial tissue outside the uterus. This is commonly associated with chronic pelvic pain, infertility, and dysmenorrhea, which occurs in approximately 10% of wom…

lab-animal 2022
Frontiers in immunology ·doi:10.3389/fimmu.2022.986202

Endometriosis is an estrogen-dependent gynecological disease with chronic pelvic inflammation. In order to study the pathophysiology of endometriosis and examine the therapeutic effects of new pharmaceuticals for endometriosis treatment, di…

case-report 2022
·doi:10.22514/ejgo.2022.065

Serous carcinoma arising in adenomyosis is rare, with only 8 cases reported in the literature. Primary small cell carcinoma of the ovary-the pulmonary type (SCCOPT) is a rare and aggressive entity associated with poor outcomes and limited t…

case-report 2022
·doi:10.21203/rs.3.rs-1374888/v1

Abstract Background: Serous carcinoma arising in adenomyosis is rare, only 8 cases have been reported in the literature. Primary small cell carcinoma of ovary - pulmonary type (SCOOPT) is a rare, aggressive entity associated with poor outco…

nonrandomized-trial 2022
Cellular and molecular biology (Noisy-le-Grand, France) ·doi:10.14715/cmb/2021.67.4.38

Endometriosis is a gynecological disease that endometrial cells develop outside the uterus. This event happens when the endometrial glands grow outside the endometrium and uterine muscles, especially in the pelvis. Although endometriosis is…

2021
·doi:10.1016/b978-0-12-820661-4.00001-7
lab-animal 2021
Oncology letters ·doi:10.3892/ol.2021.12688

Endometrial cancer (EC) is a multi-factorial disease of which pathogenesis has not been fully elucidated. The function and underlying mechanism of microRNA-20a-5p (miR-20a-5p) in EC remain poorly understood. The present study aimed to analy…

lab-animal 2021
Frontiers in immunology ·doi:10.3389/fimmu.2021.641206

Endometriosis is a common, benign, and hormone-dependent gynaecological disorder that displays altered immunoinflammatory profiles. Myeloid-derived suppressor cells (MDSCs) suppressed immunosurveillance in endometriosis in human and mouse m…

nonrandomized-trial 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00115

Research Question: What is the effect of gonadotropin-releasing hormone (GnRH)-agonist treatment on serum anti-Müllerian hormone (AMH)? Design: This prospective cohort study conducted in a tertiary university hospital comprised patients (n …

case-report 2018
Medicine ·doi:10.1097/md.0000000000011330

RATIONALE: Ovarian malignancy is associated with one of the highest rates of death among gynecological reproductive system malignancies. While progress has been made in surgical and postoperative adjuvant treatment approaches, the early aty…